Welcure Drugs And Pharmaceuticals Ltd. Press Release Apr 03 2026
Filed with BSE · · 2 pages · English
Summary by 6ix AI
It confirms that no physical share certificates were received for dematerialization of securities from the depository participant of Welcure Drugs and Pharmaceuticals Ltd. The certificate was submitted by Skyline Financial Services Pvt. Ltd. on behalf of Welcure Drugs and Pharmaceuticals Ltd.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Welcure Drugs and Pharmaceuticals Ltd. on 6ix
Story so far
Earlier from Welcure Drugs and Pharmaceuticals
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Mar 26 2026
- Closure of Trading Window
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Jan 05 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Dec 24 2025
Later from Welcure Drugs and Pharmaceuticals
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Apr 23 2026
- Compliances-Reg.24(A)-Annual Secretarial Compliance
- Welcure Drugs And Pharmaceuticals Ltd. Press Release May 30 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Jun 01 2026
Follow Welcure Drugs and Pharmaceuticals into a list and get an email when it puts out news.
Follow Welcure Drugs and Pharmaceuticals